Quanticate names new VP of business development
This article was originally published in Scrip
The specialist biometrics CRO Quanticate has appointed Dr Daniel Chapple vice-president of business development and marketing. Dr Chapple joins the CRO from Cognizant's Life Sciences BPO practice, where he was general manager. He has also held leadership positions at ICON Clinical Research and the now defunct MDS Pharma Services.
You may also be interested in...
Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.
"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"